SBL
TTPH

Sargent Bickham Lagudis’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Sargent Bickham Lagudis’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$3K – 854
2020
Q2 		$3K Buy
+1,000
New +$1.9K ﹤0.01% 696

Sargent Bickham Lagudis's TTPH Position: Q3 2020 in Review

Sargent Bickham Lagudis sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in TTPH in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

  • Sargent Bickham Lagudis reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 1,000 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3K.
  • Sargent Bickham Lagudis first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Sargent Bickham Lagudis's Tetraphase Pharmaceuticals, Inc. position peaked at $3K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2020, filed 1 Sep 2021.